AI is transforming the way amyloidosis is diagnosed and treated. This session explains how new tools improve early detection, guide doctors in treatment choices, and give patients clearer paths forward—bringing hope for better outcomes and quality of life.

Join us for Office Hours with Dr. Mazen Hanna, leading cardiologist and Co-Director of the Cleveland Clinic’s Amyloidosis Program. This is your chance to ask questions and learn directly from a top expert in cardiac amyloidosis and heart failure care.

Dr. Mazen Hanna is a staff cardiologist at Cleveland Clinic, serving as Director of the Heart Failure ICU and Co‑Director of the Amyloidosis Program. He’s board-certified in cardiology, advanced heart failure, transplant, and specializes in cardiomyopathies and cardiac amyloidosis.